Director Reyes Javier A purchased 103 shares of CHCO at $126.36; cluster of 3 other insiders buying within 14 days
Director Reyes Javier A acquired 103 shares at $126.36 on 2026-04-20, increasing his holdings by 4.7% to 2,285 shares. This purchase is part of a broader cluster, with 3 other insiders also buying within the past 14 days, suggesting coordinated interest. Across his prior trades at CHCO, the director has demonstrated selective timing: 2 of 3 prior buys at this ticker were well-timed at the 90-day mark. The stock trades at a P/E of 12.84 with recent 30-day appreciation of 7.8%, though currently -5.6% from its 52-week high. The company generated $35.2M net income on $16.2M quarterly revenue, with annual growth of 3.2%.
Director Javier A Reyes bought 105 shares of CHCO at $115.88; 3 other insiders also bought within 14 days.
Director Javier A Reyes purchased 105 shares at $115.88 on 2026-03-09, increasing his holdings by 5.1% to 2,182 shares total. This transaction occurs as part of a cluster buy pattern, with 3 other insiders also purchasing shares within the past 14 days, suggesting coordinated or independently aligned conviction in the stock at current levels. The stock has declined 8.4% over the past 30 days and 4.7% over 90 days, trading at $117.16 (12.3% below the 52-week high), which provides context for the purchase timing. Reyes' prior trades at CHCO show a mixed timing pattern: 2 of his 3 preceding buys at this ticker realized positive 90-day returns (+2.9% and +4.9%), though his cross-ticker track record across all holdings shows a 66.67% 90-day win rate at an average return of +1.4%, suggesting modest consistency but not exceptional predictive accuracy.
Director Reyes Javier A purchased 105 shares of CHCO at $117.23; cluster buy pattern with 2 other insiders in 14 days
Director Reyes Javier A purchased 105 shares at $117.23 on 2025-10-16, expanding his holdings from 1,707 to 1,812 shares (+6.2%). The purchase arrives within a 14-day cluster in which 2 other insiders also bought, suggesting coordinated confidence in the stock's trajectory. His cross-ticker track record shows 2 prior buys with a 90-day win rate of 100.00% and average 90-day returns of +3.6%, though CHCO-specific history is more recent and limited. CHCO's fundamentals include a market cap of $1,730,972,718.02, annual revenue growth of +4.2%, and a P/E of 14.17, while the current stock price of $119.42 sits 11.1% below the 52-week high, having declined 3.8% over 30 days. The convergence of multiple insider purchases at a post-decline valuation point is the primary signal warrant investor attention.
Director Javier A Reyes buys 90 CHCO shares at $127.05; cluster pattern with 2 other insiders buying in past 14 days
Director Javier A Reyes purchased 90 shares at $127.05 on 2025-07-28, raising his holdings from 1,617 to 1,707 shares (a +5.6% increase). The transaction occurred at a price $1.64 above the current market price of $125.41, and the stock has risen 8.2% over the past 90 days from its lows. Notably, 2 other insiders also bought within the past 14 days, indicating a cluster buy pattern during a period of positive momentum. Reyes' cross-ticker track record shows 1 prior buy with an average 30-day return of +1.0%, and his single prior CHCO purchase on 2025-05-07 also achieved a +1.0% 30-day return, though the 90-day outcome on that trade remains immeasurable. The company's fundamentals show solid positioning with a P/E of 15.41 and net income of $30.3M, though quarterly revenue of $16.2M with annual growth of +4.2% reflects moderate organic expansion. The synchronized buying activity across multiple directors warrants attention to whether this reflects management confidence or routine portfolio activity.
Director Reyes Javier A purchases 116 CHCO shares at $116.72; 4 other insiders also bought within 14 days
Director Reyes Javier A acquired 116 shares of CITY HOLDING CO at $116.72 on 2025-05-07, increasing his holdings from 1,501 shares to 1,617 shares. This purchase occurs within a broader pattern: 4 other insiders also bought within the past 14 days, forming a cluster buy signal. The director's transaction represents a 7.7% increase to his prior holdings, indicating material accumulation by a board member. At the current price of $119.14, the stock trades 11.3% below its 52-week high but is up 7.9% over the past 30 days, suggesting recent positive momentum; the company's fundamentals show reasonable health with a P/E of 14.64 and net income of $30.3M on quarterly revenue of $16.2M.
